Andrew Jess Dannenberg

Andrew Jess Dannenberg's AcademicInfluence.com Rankings

Philosophy

#5842

World Rank

#8757

Historical Rank

Logic

#3208

World Rank

#4331

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Andrew Jess Dannenberg's Degrees

Doctorate Medicine Johns Hopkins University
PhD Biomedical Engineering Johns Hopkins University

Why Is Andrew Jess Dannenberg Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Andrew Jess Dannenberg is a U.S. physician and former researcher specializing in molecular mechanisms of cancer, formerly associated with Weill Medical College/M.D. Anderson Cancer Center. Beginning in 2020 some of Dannenberg's published papers were retracted due to irregularities with the data or figures.

(See a Problem?)

Andrew Jess Dannenberg's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

COX‐2 is expressed in human pulmonary, colonic, and mammary tumors (2000) (897)
Resveratrol Inhibits Cyclooxygenase-2 Transcription and Activity in Phorbol Ester-treated Human Mammary Epithelial Cells* (1998) (781)
Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck. (1999) (758)
Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer. (1999) (727)
Cyclooxygenase 2: a molecular target for cancer prevention and treatment. (2003) (663)
Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis. (1996) (615)
Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors. (2007) (588)
Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer. (2001) (533)
Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells. (1996) (472)
Targeting cyclooxygenase-2 in human neoplasia: rationale and promise. (2003) (468)
Cox-2 is regulated by Toll-like receptor-4 (TLR4) signaling: Role in proliferation and apoptosis in the intestine. (2006) (453)
Obesity and Cancer Mechanisms: Tumor Microenvironment and Inflammation. (2016) (441)
Inflammation and Increased Aromatase Expression Occur in the Breast Tissue of Obese Women with Breast Cancer (2011) (414)
Cyclooxygenase-2 and epidermal growth factor receptor: pharmacologic targets for chemoprevention. (2005) (401)
MicroRNA Expression in Squamous Cell Carcinoma and Adenocarcinoma of the Esophagus: Associations with Survival (2009) (390)
Inhibition of Cyclooxygenase-2 Gene Expression by p53* (1999) (376)
Inhibitory effects of caffeic acid phenethyl ester on the activity and expression of cyclooxygenase-2 in human oral epithelial cells and in a rat model of inflammation. (1999) (372)
Obesity Is Associated with Inflammation and Elevated Aromatase Expression in the Mouse Mammary Gland (2011) (368)
Cyclooxygenase-2 is overexpressed in human cervical cancer. (2001) (348)
Cyclooxygenase-2: a target for the prevention and treatment of breast cancer. (2001) (340)
Treatment and Prevention of Intraepithelial Neoplasia: An Important Target for Accelerated New Agent Development: Recommendations of the American Association for Cancer Research Task Force on the Treatment and Prevention of Intraepithelial Neoplasia (2002) (339)
Cyclooxygenase-2 Is Overexpressed in HER-2/neu-positive Breast Cancer (2002) (339)
Microtubule-interfering Agents Stimulate the Transcription of Cyclooxygenase-2 (2000) (317)
A novel synthetic oleanane triterpenoid, 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid, with potent differentiating, antiproliferative, and anti-inflammatory activity. (1999) (302)
Curcumin prevents alcohol-induced liver disease in rats by inhibiting the expression of NF-kappa B-dependent genes. (2003) (297)
Curcumin inhibits cyclooxygenase-2 transcription in bile acid- and phorbol ester-treated human gastrointestinal epithelial cells. (1999) (284)
The obese adipose tissue microenvironment in cancer development and progression (2018) (283)
Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk (2004) (277)
Celecoxib, a selective cyclo-oxygenase-2 inhibitor, enhances the response to preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer. (2003) (273)
Molecular Pathways: Adipose Inflammation as a Mediator of Obesity-Associated Cancer (2013) (272)
Peroxisome proliferator-activated receptor gamma ligands suppress the transcriptional activation of cyclooxygenase-2. Evidence for involvement of activator protein-1 and CREB-binding protein/p300. (2001) (272)
Progress in Chemoprevention Drug Development: The Promise of Molecular Biomarkers for Prevention of Intraepithelial Neoplasia and Cancer—A Plan to Move Forward (2006) (272)
Markedly enhanced cytochrome P450 2E1 induction and lipid peroxidation is associated with severe liver injury in fish oil-ethanol-fed rats. (1994) (270)
15-Hydroxyprostaglandin dehydrogenase is an in vivo suppressor of colon tumorigenesis (2006) (255)
Increased levels of COX-2 and prostaglandin E2 contribute to elevated aromatase expression in inflamed breast tissue of obese women. (2012) (237)
Treatment and prevention of intraepithelial neoplasia: an important target for accelerated new agent development. (2002) (234)
Inducible microsomal prostaglandin E synthase is overexpressed in colorectal adenomas and cancer. (2001) (233)
Inhibition of Cyclooxygenase: A Novel Approach to Cancer Prevention (1997) (232)
Obesity-dependent changes in interstitial ECM mechanics promote breast tumorigenesis (2015) (230)
Celecoxib Inhibits Prostate Cancer Growth: Evidence of a Cyclooxygenase-2-Independent Mechanism (2005) (226)
Celecoxib, a selective cyclooxygenase 2 inhibitor, protects against human epidermal growth factor receptor 2 (HER-2)/neu-induced breast cancer. (2002) (224)
Cyclooxygenase‐2: A novel molecular target for the prevention and treatment of head and neck cancer (2002) (219)
Regulation of Cyclooxgenase-2 mRNA Stability by Taxanes (2003) (216)
Dihydroxy Bile Acids Activate the Transcription of Cyclooxygenase-2* (1998) (211)
Adipose-Resident Group 1 Innate Lymphoid Cells Promote Obesity-Associated Insulin Resistance. (2016) (207)
Obesity and cancer: local and systemic mechanisms. (2015) (204)
Inducible prostaglandin E synthase is overexpressed in non-small cell lung cancer. (2001) (198)
Ceramide Regulates the Transcription of Cyclooxygenase-2 (1998) (196)
Transcriptional activation of cyclooxygenase-2 in Wnt-1-transformed mouse mammary epithelial cells. (1999) (191)
Regulation of Cyclooxygenase-2 by Interferon γ and Transforming Growth Factor α in Normal Human Epidermal Keratinocytes and Squamous Carcinoma Cells (1999) (189)
Enhanced cyclooxygenase-2 gene expression in alcoholic liver disease in the rat. (1997) (186)
Sphingolipid signaling in metabolic disorders. (2012) (179)
Secondary chemoprevention of Barrett's esophagus with celecoxib: results of a randomized trial. (2007) (175)
Obesity alters the lung myeloid cell landscape to enhance breast cancer metastasis through IL5 and GM-CSF (2017) (168)
Ursolic acid inhibits cyclooxygenase-2 transcription in human mammary epithelial cells. (2000) (166)
Retinoids suppress epidermal growth factor-induced transcription of cyclooxygenase-2 in human oral squamous carcinoma cells. (1997) (165)
Increased severity of alcoholic liver injury in female rats: role of oxidative stress, endotoxin, and chemokines. (2001) (162)
Obesity is Associated with Worse Outcomes in COVID‐19: Analysis of Early Data from New York City (2020) (160)
Benzo[a]pyrene up-regulates cyclooxygenase-2 gene expression in oral epithelial cells. (1997) (159)
HER2/neu-induced mammary tumorigenesis and angiogenesis are reduced in cyclooxygenase-2 knockout mice. (2005) (158)
Phenotypic abnormalities in macrophages from leptin-deficient, obese mice. (1999) (158)
Obesity, Inflammation and Cancer (2013) (153)
The sulfide metabolite of sulindac prevents tumors and restores enterocyte apoptosis in a murine model of familial adenomatous polyposis. (1998) (151)
Effects of Cigarette Smoke on the Human Oral Mucosal Transcriptome (2010) (151)
Pathology of Peripheral Artery Disease in Patients With Critical Limb Ischemia. (2018) (149)
Lung inflammation promotes metastasis through neutrophil protease-mediated degradation of Tsp-1 (2015) (149)
Obesity, Energy Balance, and Cancer: New Opportunities for Prevention (2012) (149)
Duodenal reflux induces cyclooxygenase-2 in the esophageal mucosa of rats: evidence for involvement of bile acids. (2001) (149)
Systemic Correlates of White Adipose Tissue Inflammation in Early-Stage Breast Cancer (2015) (143)
Selective visualization of cyclooxygenase-2 in inflammation and cancer by targeted fluorescent imaging agents. (2010) (142)
PEA3 Is Up-regulated in Response to Wnt1 and Activates the Expression of Cyclooxygenase-2* (2001) (141)
Thalidomide and its analogues inhibit lipopolysaccharide-mediated Iinduction of cyclooxygenase-2. (2001) (137)
Retinoids and carnosol suppress cyclooxygenase-2 transcription by CREB-binding protein/p300-dependent and -independent mechanisms. (2002) (136)
Association of Body Fat and Risk of Breast Cancer in Postmenopausal Women With Normal Body Mass Index: A Secondary Analysis of a Randomized Clinical Trial and Observational Study (2019) (135)
Levels of cyclooxygenase-2 are increased in the oral mucosa of smokers: evidence for the role of epidermal growth factor receptor and its ligands. (2005) (134)
Cyclooxygenase-2 in human pathological disease. (2002) (131)
Obesity and breast cancer prognosis: weight of the evidence. (2011) (130)
Obesity and inflammation: new insights into breast cancer development and progression. (2013) (129)
Dietary saturated fatty acids down‐regulate cyclooxygenase‐2 and tumor necrosis factor alfa and reverse fibrosis in alcohol‐induced liver disease in the rat (1997) (128)
Transforming Cancer Prevention through Precision Medicine and Immune-oncology (2016) (128)
Aspirin prevents tumors in a murine model of familial adenomatous polyposis. (1998) (127)
Cyclooxygenase-2 transcription is regulated by human papillomavirus 16 E6 and E7 oncoproteins: evidence of a corepressor/coactivator exchange. (2007) (126)
Ethanol and Arachidonic Acid Increase α2(I) Collagen Expression in Rat Hepatic Stellate Cells Overexpressing Cytochrome P450 2E1 (2000) (124)
Association between regional body fat and cardiovascular disease risk among postmenopausal women with normal body mass index. (2019) (116)
Benzo[a]pyrene Induces the Transcription of Cyclooxygenase-2 in Vascular Smooth Muscle Cells (2000) (115)
(+)-Catechin inhibits intestinal tumor formation and suppresses focal adhesion kinase activation in the min/+ mouse. (2001) (111)
HDAC6 Modulates Hsp90 Chaperone Activity and Regulates Activation of Aryl Hydrocarbon Receptor Signaling* (2009) (111)
IL-6–Mediated Induction of Matrix Metalloproteinase-9 Is Modulated by JAK-Dependent IL-10 Expression in Macrophages (2014) (109)
Levels of Prostaglandin E Metabolite and Leukotriene E4 Are Increased in the Urine of Smokers: Evidence that Celecoxib Shunts Arachidonic Acid into the 5-Lipoxygenase Pathway (2009) (108)
Dietary saturated fatty acids: a novel treatment for alcoholic liver disease. (1995) (107)
Retinoids suppress phorbol ester-mediated induction of cyclooxygenase-2. (1997) (107)
Metabolic Obesity, Adipose Inflammation and Elevated Breast Aromatase in Women with Normal Body Mass Index (2017) (107)
Targeting Prostaglandin E2 Receptors as an Alternative Strategy to Block Cyclooxygenase-2-dependent Extracellular Matrix-induced Matrix Metalloproteinase-9 Expression by Macrophages* (2006) (106)
Inhibition of Cyclooxygenase‐2 Expression: An Approach to Preventing Head and Neck Cancer (1999) (105)
HER-2/neu status is a determinant of mammary aromatase activity in vivo: evidence for a cyclooxygenase-2-dependent mechanism. (2006) (103)
Chemoprevention of colorectal cancer through inhibition of cyclooxygenase-2. (1999) (102)
Weight management and physical activity throughout the cancer care continuum (2017) (99)
Cyclooxygenase-2 and Microsomal Prostaglandin E Synthase-1 Are Overexpressed in Squamous Cell Carcinoma of the Penis (2004) (98)
Matrix Metalloproteinase (MMP)-1 and MMP-3 Induce Macrophage MMP-9: Evidence for the Role of TNF-α and Cyclooxygenase-21 (2009) (94)
Pilot Randomized Phase II Study of Celecoxib in Oral Premalignant Lesions (2008) (94)
Identification of Macrophage Extracellular Trap-Like Structures in Mammary Gland Adipose Tissue: A Preliminary Study (2013) (93)
Dietary saturated fatty acids reverse inflammatory and fibrotic changes in rat liver despite continued ethanol administration. (2001) (92)
Transcriptomic signatures related to the obesity paradox in patients with clear cell renal cell carcinoma: a cohort study. (2019) (92)
Histone Deacetylase Inhibitors Suppress the Induction of c-Jun and Its Target Genes Including COX-2* (2005) (92)
Alcoholic Liver Injury in the Rat Is Associated with Reduced Expression of Peroxisome Proliferator-α (PPARα)-Regulated Genes and Is Ameliorated by PPARα Activation (2004) (91)
Resveratrol Inhibits Cyclooxygenase‐2 Transcription in Human Mammary Epithelial Cells (1999) (91)
Regulation of cyclooxygenase-2 by interferon gamma and transforming growth factor alpha in normal human epidermal keratinocytes and squamous carcinoma cells. Role of mitogen-activated protein kinases. (1999) (90)
Microsomal Prostaglandin E Synthase-1 Is Overexpressed in Inflammatory Bowel Disease (2004) (88)
COX-2 in cancer--a player that's defining the rules. (2002) (88)
Administration of an unconjugated bile acid increases duodenal tumors in a murine model of familial adenomatous polyposis. (1999) (87)
Tobacco smoke induces CYP1B1 in the aerodigestive tract. (2004) (87)
Heartburn risk factors, knowledge, and prevention strategies: a population-based survey of individuals with heartburn. (1999) (85)
A role for cyclooxygenase-2 inhibitors in the prevention and treatment of cancer. (2002) (84)
Menopause Is a Determinant of Breast Adipose Inflammation (2015) (82)
Determination of endogenous tissue inflammation profiles by LC/MS/MS: COX- and LOX-derived bioactive lipids. (2006) (79)
Inhibition of Cyclooxygenase‐2 (2001) (78)
Macrophages induce COX-2 expression in breast cancer cells: role of IL-1β autoamplification. (2011) (77)
Exocytosis of macrophage lysosomes leads to digestion of apoptotic adipocytes and foam cell formation[S] (2016) (76)
Changes in cytochromes P-450, 2E1, 2B1, and 4A, and phospholipases A and C in the intragastric feeding rat model for alcoholic liver disease: relationship to dietary fats and pathologic liver injury. (1994) (76)
Levels of NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase are reduced in inflammatory bowel disease: evidence for involvement of TNF-alpha. (2006) (74)
High-Fat Diet Accelerates Carcinogenesis in a Mouse Model of Barrett's Esophagus via Interleukin 8 and Alterations to the Gut Microbiome. (2019) (73)
Medium chain triglycerides and vitamin E reduce the severity of established experimental alcoholic liver disease. (1996) (70)
EP2 and EP4 Receptors Regulate Aromatase Expression in Human Adipocytes and Breast Cancer Cells (2008) (69)
Motivation for Health Information Seeking and Processing About Clinical Trial Enrollment (2010) (69)
Dietary fructose improves intestinal cell survival and nutrient absorption (2021) (69)
IRE1α–XBP1 signaling in leukocytes controls prostaglandin biosynthesis and pain (2019) (68)
Microsomal prostaglandin E synthase-1 is overexpressed in head and neck squamous cell carcinoma. (2003) (68)
Metabolic Dysfunction, Obesity, and Survival Among Patients With Early-Stage Colorectal Cancer. (2016) (66)
Increased Levels of Urinary PGE-M, a Biomarker of Inflammation, Occur in Association with Obesity, Aging, and Lung Metastases in Patients with Breast Cancer (2013) (66)
Menopause Is a Determinant of Breast Aromatase Expression and Its Associations With BMI, Inflammation, and Systemic Markers (2017) (66)
Epidermal Growth Factor–Induced Cyclooxygenase-2 Expression Is Mediated through Phosphatidylinositol-3 Kinase, Not Mitogen-Activated Protein/Extracellular Signal-Regulated Kinase Kinase, in Recurrent Respiratory Papillomas (2005) (65)
Effects of Tobacco Smoke on Gene Expression and Cellular Pathways in a Cellular Model of Oral Leukoplakia (2008) (65)
Levels of Prostaglandin E Metabolite, the Major Urinary Metabolite of Prostaglandin E2, Are Increased in Smokers (2005) (62)
Phase II Study of Celecoxib and Trastuzumab in Metastatic Breast Cancer Patients Who Have Progressed after Prior Trastuzumab-Based Treatments (2004) (62)
National Cancer Institute workshop on chemopreventive properties of nonsteroidal anti-inflammatory drugs: role of COX-dependent and -independent mechanisms. (2002) (61)
Tobacco smoke stimulates the transcription of amphiregulin in human oral epithelial cells: evidence of a cyclic AMP-responsive element binding protein-dependent mechanism. (2005) (61)
Prostaglandin E2 inhibits transforming growth factor β1-mediated induction of collagen α1(I) in hepatic stellate cells (2004) (61)
Obesity‐induced lymphatic dysfunction is reversible with weight loss (2016) (60)
Phase II, randomized, placebo-controlled trial of neoadjuvant celecoxib in men with clinically localized prostate cancer: evaluation of drug-specific biomarkers. (2009) (60)
Changes in microsomal phospholipases and arachidonic acid in experimental alcoholic liver injury: relationship to cytochrome P-450 2E1 induction and conjugated diene formation. (1993) (59)
Chemotherapy Induces the Expression of Cyclooxygenase-2 in Non–Small Cell Lung Cancer (2005) (59)
Impact of obesity on the survival of patients with early‐stage squamous cell carcinoma of the oral tongue (2014) (59)
Cox-2-derived PGE2 induces Id1-dependent radiation resistance and self-renewal in experimental glioblastoma. (2016) (58)
Gastrointestinal Manifestations of Epidermolysis Bullosa A Study of 101 Patients (1992) (57)
Alcoholic liver injury in the rat is associated with reduced expression of peroxisome proliferator-alpha (PPARalpha)-regulated genes and is ameliorated by PPARalpha activation. (2004) (55)
Disorders of the rectus abdominis muscle and sheath: a 22-year experience. (1995) (55)
Sphingosine kinases are not required for inflammatory responses in macrophages. (2016) (55)
Enzymatic Activity of HPGD in Treg Cells Suppresses Tconv Cells to Maintain Adipose Tissue Homeostasis and Prevent Metabolic Dysfunction. (2019) (54)
The retinoid X receptor-selective retinoid, LGD1069, down-regulates cyclooxygenase-2 expression in human breast cells through transcription factor crosstalk: implications for molecular-based chemoprevention. (2005) (54)
Combined Targeting of the Epidermal Growth Factor Receptor and Cyclooxygenase-2 Pathways (2005) (54)
Characterization of cyclooxygenase-2 (COX-2) during tumorigenesis in human epithelial cancers: evidence for potential clinical utility of COX-2 inhibitors in epithelial cancers. (2002) (53)
Heat Shock Protein 90 Inhibitors Suppress Aryl Hydrocarbon Receptor–Mediated Activation of CYP1A1 and CYP1B1 Transcription and DNA Adduct Formation (2008) (53)
From information processing to behavioral intentions: exploring cancer patients' motivations for clinical trial enrollment. (2010) (52)
Bile acids induce cyclooxygenase-2 expression in human pancreatic cancer cell lines. (2003) (50)
Abdominal actinomycosis: evaluation by computed tomography. (1989) (50)
Leptin regulation of the p53-HIF1α/PKM2-aromatase axis in breast adipose stromal cells – a novel mechanism for the obesity-breast cancer link (2017) (49)
COX-2 Inhibitors for the Prevention of Breast Cancer (2004) (49)
NAD+-Dependent 15-Hydroxyprostaglandin Dehydrogenase Regulates Levels of Bioactive Lipids in Non–Small Cell Lung Cancer (2008) (49)
Caloric Restriction Reverses Obesity-Induced Mammary Gland Inflammation in Mice (2013) (49)
Information Seeking Related to Clinical Trial Enrollment (2011) (49)
S1P1 localizes to the colonic vasculature in ulcerative colitis and maintains blood vessel integrity (2013) (48)
Effects of Rapid Weight Loss on Systemic and Adipose Tissue Inflammation and Metabolism in Obese Postmenopausal Women (2017) (46)
The Effect of HIV and HPV Coinfection on Cervical COX-2 Expression and Systemic Prostaglandin E2 Levels (2011) (45)
How does the microsomal membrane regulate UDP-glucuronosyltransferases? (1992) (42)
White adipose tissue inflammation and cancer‐specific survival in patients with squamous cell carcinoma of the oral tongue (2016) (42)
Inhibition of Jun NH2-Terminal Kinases Suppresses the Growth of Experimental Head and Neck Squamous Cell Carcinoma (2007) (42)
Obesity-Associated Extracellular Matrix Remodeling Promotes a Macrophage Phenotype Similar to Tumor-Associated Macrophages. (2019) (42)
Prostaglandin E2 inhibits transforming growth factor beta 1-mediated induction of collagen alpha 1(I) in hepatic stellate cells. (2004) (41)
Comparative effects of omeprazole on xenobiotic metabolizing enzymes in the rat and human (1995) (41)
Metabolic Profiling, a Noninvasive Approach for the Detection of Experimental Colorectal Neoplasia (2012) (41)
Liver microsomal fatty acid composition in ethanol-fed rats: effect of different dietary fats and relationship to liver injury. (1994) (41)
Obesity-Associated Alterations in Inflammation, Epigenetics, and Mammary Tumor Growth Persist in Formerly Obese Mice (2016) (40)
Cyclooxygenase-2 Expression in the Developing Human Kidney (2001) (40)
The overexpression of cyclo-oxygenase-2 in chronic periodontitis. (2003) (40)
Carnosol, a Constituent of Zyflamend, Inhibits Aryl Hydrocarbon Receptor–Mediated Activation of CYP1A1 and CYP1B1 Transcription and Mutagenesis (2012) (39)
Potentially Reduced Exposure Cigarettes Accelerate Atherosclerosis: Evidence for the Role of Nicotine (2007) (39)
ID1 Is a Functional Marker for Intestinal Stem and Progenitor Cells Required for Normal Response to Injury (2014) (39)
Dietary Polyphenols Suppress Elevated Levels of Proinflammatory Mediators and Aromatase in the Mammary Gland of Obese Mice (2013) (39)
Neutrophil oxidative stress mediates obesity-associated vascular dysfunction and metastatic transmigration (2021) (39)
Matrix Metalloproteinase (MMP)-1 and MMP-3 Induce Macrophage MMP-9: Evidence for the Role of TNF- and Cyclooxygenase-2 (2009) (38)
UVR Exposure Sensitizes Keratinocytes to DNA Adduct Formation (2009) (38)
Five-year outcomes of endoscopic sleeve gastroplasty for the treatment of obesity. (2020) (38)
Dietary lipids coinduce xenobiotic metabolizing enzymes in rat liver. (1993) (37)
Development and Use of a Gene Promoter-Based Screen to Identify Novel Inhibitors of Cyclooxygenase-2 Transcription (2001) (37)
Targeted over-expression of mPGES-1 and elevated PGE2 production is not sufficient for lung tumorigenesis in mice. (2004) (36)
Dietary Fructose Alters the Composition, Localization, and Metabolism of Gut Microbiota in Association With Worsening Colitis (2020) (36)
Creatine-mediated crosstalk between adipocytes and cancer cells regulates obesity-driven breast cancer. (2020) (35)
p53 Protein Regulates Hsp90 ATPase Activity and Thereby Wnt Signaling by Modulating Aha1 Expression* (2014) (34)
Multiphoton Tomographic Imaging: A Potential Optical Biopsy Tool for Detecting Gastrointestinal Inflammation and Neoplasia (2012) (33)
Docked severe acute respiratory syndrome coronavirus 2 proteins within the cutaneous and subcutaneous microvasculature and their role in the pathogenesis of severe coronavirus disease 2019 (2020) (32)
Combination Chemoprevention of HER2/neu-Induced Breast Cancer Using a Cyclooxygenase-2 Inhibitor and a Retinoid X Receptor–Selective Retinoid (2008) (32)
The role of COX-2 in breast and cervical cancer. (2003) (31)
Exogenous and Endogenous Sources of Serine Contribute to Colon Cancer Metabolism, Growth, and Resistance to 5-Fluorouracil (2021) (31)
Individuals' Willingness to Talk to Their Doctors About Clinical Trial Enrollment (2010) (31)
Sulindac Derivatives That Activate the Peroxisome Proliferator-activated Receptor γ but Lack Cyclooxygenase Inhibition (2008) (30)
Leptin and Adiponectin Modulate the Self-renewal of Normal Human Breast Epithelial Stem Cells (2015) (30)
Adiposity, Inflammation, and Breast Cancer Pathogenesis in Asian Women (2017) (29)
Improvement in Insulin Resistance and Estimated Hepatic Steatosis and Fibrosis after Endoscopic Sleeve Gastroplasty. (2020) (29)
Gender-related differences in the amount and functional state of rat liver UDP-glucuronosyltransferase. (1995) (29)
Celecoxib Alters the Intestinal Microbiota and Metabolome in Association with Reducing Polyp Burden (2016) (28)
A Small-Molecule Pan-Id Antagonist Inhibits Pathologic Ocular Neovascularization (2019) (27)
Inactivating Mutation in the Prostaglandin Transporter Gene, SLCO2A1, Associated with Familial Digital Clubbing, Colon Neoplasia, and NSAID Resistance (2014) (27)
Cyclooxygenase-2-derived Prostaglandin E2 Stimulates Id-1 Transcription* (2008) (27)
Genetic deletion of microsomal prostaglandin E synthase-1 suppresses mouse mammary tumor growth and angiogenesis. (2013) (26)
FGFR1 underlies obesity-associated progression of estrogen receptor-positive breast cancer after estrogen deprivation. (2018) (26)
AACR White Paper: Shaping the Future of Cancer Prevention – A Roadmap for Advancing Science and Public Health (2018) (26)
Pioglitazone, a PPARγ Agonist, Suppresses CYP19 Transcription: Evidence for Involvement of 15-Hydroxyprostaglandin Dehydrogenase and BRCA1 (2012) (26)
Elevated Levels of Urinary Prostaglandin E Metabolite Indicate a Poor Prognosis in Ever Smoker Head and Neck Squamous Cell Carcinoma Patients (2009) (26)
Sleep and Breathing … and Cancer? (2016) (25)
Resveratrol inhibits the expression of cyclooxygenase-2 in mammary epithelial cells. (2001) (25)
Glucuronidation of the lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) by rat UDP-glucuronosyltransferase 2B1. (1999) (25)
Estrogen Protects against Obesity-Induced Mammary Gland Inflammation in Mice (2015) (25)
Effect of dietary lipids on levels of UDP-glucuronosyltransferase in liver. (1992) (25)
Targeting obesity-related adipose tissue dysfunction to prevent cancer development and progression. (2016) (24)
Development and use of a gene promoter-based screen to identify novel inhibitors of cyclooxygenase-2 transcription. (2001) (24)
Desmethyl derivatives of indomethacin and sulindac as probes for cyclooxygenase-dependent biology. (2007) (24)
Peroxisome Proliferator-activated Receptor γ Ligands Suppress the Transcriptional Activation of Cyclooxygenase-2 (2001) (24)
Elevated expression of cyclooxygenase-2 contributes to immune dysfunction in a murine model of trauma. (2001) (24)
COX-2 inhibition in upper aerodigestive tract tumors. (2004) (23)
Dietary lipid regulates the amount and functional state of UDP-glucuronosyltransferase in rat liver. (1992) (23)
Tobacco smoke induces urokinase-type plasminogen activator and cell invasiveness: evidence for an epidermal growth factor receptor dependent mechanism. (2007) (23)
Workshop on imaging science development for cancer prevention and preemption. (2006) (23)
Cyclooxygenase-2 gene expression is upregulated in transformed mammary epithelial cells. (1997) (23)
Matrix Metalloproteinase-Dependent Microsomal Prostaglandin E Synthase-1 Expression in Macrophages: Role of TNF-α and the EP4 Prostanoid Receptor (2012) (23)
Regulation of UDP-glucuronosyltransferase by lipid-protein interactions. Comparison of the thermotropic properties of pure reconstituted enzyme with microsomal enzyme. (1989) (22)
Ceramide Regulates the Transcription of Cyclooxygenase-2 EVIDENCE FOR INVOLVEMENT OF EXTRACELLULAR SIGNAL-REGULATED KINASE/c-Jun N-TERMINAL KINASE AND p38 MITOGEN-ACTIVATED PROTEIN KINASE PATHWAYS* (1998) (22)
Induction of cyclooxygenase-2 by tumor promoters in transformed and cytochrome P450 2E1-expressing hepatocytes. (2002) (22)
Applying the theory of planned behavior to study health decisions related to potential risks (2010) (21)
Carcinoid tumor metastatic to the heart. (1990) (21)
Regulation of uridine diphosphate glucuronosyltransferase expression by phenolic antioxidants. (1994) (20)
Bile acids inhibit NAD+-dependent 15-hydroxyprostaglandin dehydrogenase transcription in colonocytes. (2009) (20)
p53 Modulates Hsp90 ATPase Activity and Regulates Aryl Hydrocarbon Receptor Signaling (2014) (20)
Sphingosine Kinases Are Not Required for Inflammatory Responses in Macrophages* (2013) (20)
UV Radiation Inhibits 15-Hydroxyprostaglandin Dehydrogenase Levels in Human Skin: Evidence of Transcriptional Suppression (2010) (20)
Effect of Zileuton and Celecoxib on Urinary LTE4 and PGE-M Levels in Smokers (2013) (19)
Eosinophilic ascites due to hyperinfection with Strongyloides stercoralis. (1991) (19)
Resveratrol inhibits the expression of cyclooxygenase-2 in human mammary and oral epithelial cells (1998) (17)
Prostaglandin E2 down-regulates sirtuin 1 (SIRT1), leading to elevated levels of aromatase, providing insights into the obesity–breast cancer connection (2018) (17)
Organization of microsomal UDP-glucuronosyltransferase. Activation by treatment at high pressure. (1990) (17)
Bryostatin-1 stimulates the transcription of cyclooxygenase-2: evidence for an activator protein-1-dependent mechanism. (2003) (16)
Cox-2 : a new target for cancer prevention and treatment (2003) (16)
The Prostaglandin Transporter Regulates Adipogenesis and Aromatase Transcription (2011) (16)
Obesity, Inflammation, and Breast Cancer (2013) (15)
Synergistic Effects of 13-cis Retinoic Acid and Arachidonic Acid Cascade Inhibitors on Growth of Head and Neck Squamous Cell Carcinoma in Vitro (1998) (15)
Breast cancer risk reduction: no pain, no gain? (2012) (15)
A Randomized Multicenter Phase II Study of Docosahexaenoic Acid in Patients with a History of Breast Cancer, Premalignant Lesions, or Benign Breast Disease (2018) (15)
Pioglitazone Inhibits Periprostatic White Adipose Tissue Inflammation in Obese Mice (2017) (14)
Thermal stability of microsomal glucose-6-phosphatase. (1990) (14)
Benzo[a]pyrene phenols are more potent inducers of CYP1A1, CYP1B1 and COX-2 than benzo[a]pyrene glucuronides in cell lines derived from the human aerodigestive tract. (2003) (14)
Dannenberg-independent Mechanisms Transcription by CREB-binding Protein / p 300-dependent and Retinoids and Carnosol Suppress Cyclooxygenase-2 Updated Version (2002) (14)
Noninvasive Detection of Inflammatory Changes in White Adipose Tissue by Label-Free Raman Spectroscopy. (2016) (14)
Scurvy and the gastrointestinal tract. (1997) (14)
A web-based screening and accrual strategy for a cancer prevention clinical trial in healthy smokers. (2012) (13)
Comparing Decision Making Between Cancer Patients and the General Population: Thoughts, Emotions, or Social Influence? (2012) (13)
Cancer Risk in Normal Weight Individuals with Metabolic Obesity: A Narrative Review (2021) (13)
Potential carcinogenic effects of cigarette smoke and Swedish moist snuff on pancreas: a study using a transgenic mouse model of chronic pancreatitis (2010) (12)
Multifocal adenocarcinoma of the proximal small intestine in a patient with celiac sprue. (1989) (12)
Id1 Deficiency Protects against Tumor Formation in ApcMin/+ Mice but Not in a Mouse Model of Colitis-Associated Colon Cancer (2015) (11)
Tobacco Smoke–Induced Immunologic Changes May Contribute to Oral Carcinogenesis (2014) (11)
Phenotypic abnormalities in macrophages from leptin-deficient, obese mice. (1999) (9)
The association of prediagnostic circulating levels of cardiometabolic markers, testosterone and sex hormone‐binding globulin with risk of breast cancer among normal weight postmenopausal women in the UK Biobank (2021) (9)
TGR5 Protects Against Colitis in Mice, but Vertical Sleeve Gastrectomy Increases Colitis Severity (2019) (9)
Strangulated obturator hernia: a rare cause of small bowel obstruction. (1994) (8)
The association of body fat composition with risk of breast, endometrial, ovarian and colorectal cancers among normal weight participants in the UK Biobank (2021) (8)
Effects of Adiposity and Exercise on Breast Tissue and Systemic Metabo-Inflammatory Factors in Women at High Risk or Diagnosed with Breast Cancer (2021) (8)
Cyclooxygenase-2 Expression Is Up-Regulated in Squamous Cell Carcinoma of the Head and Neck 1 (1999) (8)
Differential induction of glutathione S-transferase in rat aorta versus liver. (1994) (8)
Obesity-associated Breast Inflammation among Hispanic/Latina Breast Cancer Patients (2018) (8)
Developmental changes in the amount and functional state of UDP-glucuronosyltransferase. (1992) (8)
Gut microbiota-derived metabolites confer protection against SARS-CoV-2 infection (2022) (8)
Dietary lipids induce phase 2 enzymes in rat small intestine. (1993) (8)
Effects of high pressure on the catalytic and regulatory properties of UDP-glucuronosyltransferase in intact microsomes. (1992) (7)
Supplemental estrogen and caloric restriction reduce obesity-induced periprostatic white adipose inflammation in mice. (2019) (7)
Phorbol ester-mediated induction of cyclooxygenase-2 gene expression is inhibited by retinoids. (1997) (7)
Id1 expression in endothelial cells of the colon is required for normal response to injury. (2015) (7)
Obesity-Induced Lymphatic Dysfunction Is Reversible with Weight Loss (2016) (7)
Dietary fatty acids are also drugs (1994) (7)
Hsp90 and PKM2 Drive the Expression of Aromatase in Li-Fraumeni Syndrome Breast Adipose Stromal Cells* (2016) (6)
Effect of brief treatment at alkaline pH on the properties of UDP-glucuronosyltransferase. (1990) (6)
Combination chemoprevention of HER2/neu-induced breast cancer using a COX-2 inhibitor and an RXR-selective retinoid (2007) (6)
The association between DXA‐derived body fat measures and breast cancer risk among postmenopausal women in the Women's Health Initiative (2019) (6)
Cyclooxygenase-2: a target for the prevention and treatment of cancers of the upper digestive tract. (2003) (6)
Effects of obesity on breast aromatase expression and systemic metabo-inflammation in women with BRCA1 or BRCA2 mutations (2021) (5)
GLUT5 is a determinant of dietary fructose-mediated exacerbation of experimental colitis. (2021) (5)
Proteomic analysis of lung cancer tumors. (2006) (5)
Dietary interventions to prevent high-fructose diet–associated worsening of colitis and colitis-associated tumorigenesis in mice (2021) (5)
Anti-tumor effects of an ID antagonist with no observed acquired resistance (2021) (5)
Effects of prochlorperazine on the function of integral membrane proteins. (1988) (4)
A randomized, placebo-controlled trial of celecoxib in men prior to receiving prostatectomy for clinically localized adenocarcinoma of the prostate: Evaluation of drug-specific biomarker modulation (2007) (4)
Withdrawal: Microsomal prostaglandin E synthase-1 is overexpressed in inflammatory bowel disease: Evidence for involvement of the transcription factor Egr-1. (2020) (4)
Pioglitazone , a PPAR g Agonist , Suppresses CYP 19 Transcription : Evidence for Involvement of 15-Hydroxyprostaglandin Dehydrogenase and BRCA 1 (2012) (4)
Anti-tumor effects of an Id antagonist with no acquired resistance (2020) (4)
Title Increased levels of COX-2 and prostaglandin E 2 contribute to elevated aromatase expression in inflamed breast tissue of obese women Authors and Affiliations (2012) (4)
High-fat Diet Accelerates Carcinogenesis in a Mouse Model of Barrett’s Esophagus via IL8 and Alterations to the Gut Microbiome (2019) (4)
Human Mammary Epithelial Cells Ursolic Acid Inhibits Cyclooxygenase-2 Transcription in Updated Version (2000) (4)
Withdrawal: Regulation of cyclooxygenase-2 mRNA stability by taxanes: Evidence for involvement of p38, MAPKAPK-2, and HuR. (2020) (3)
Elevated Levels of Urinary PGE-M Are Found in Tobacco Users and Indicate a Poor Prognosis for Oral Squamous Cell Carcinoma Patients (2016) (3)
Erratum: Sphingosine kinases are not required for inflammatory responses in macrophages (The Journal of Biological Chemistry 288 (2013) 2563-32573) (2016) (3)
A Bayesian Model Averaging Approach for Observational Gene Expression Studies (2012) (3)
Withdrawal: EP2 and EP4 receptors regulate aromatase expression in human adipocytes and breast cancer cells: Evidence of a BRCA1 and p300 exchange. (2020) (3)
Withdrawal: HDAC6 modulates Hsp90 chaperone activity and regulates activation of aryl hydrocarbon receptor signaling. (2020) (3)
Obesity and menopausal status as determinants of procarcinogenic breast inflammation. (2014) (3)
Abstract PD5-05: Metabolic obesity, adipose inflammation and aromatase: Potential drivers of breast cancer risk in women with normal body mass index (2017) (3)
Factors predicting outcome after salvage treatment for stage IV oral squamous cell carcinoma: Evidence of the potential importance of the cyclooxygenase‐2–prostaglandin E2 pathway (2015) (3)
Interleukin 6 stimulates macrophage MMP‐9 expression via COX‐2‐dependent induction of PGE2 synthesis and engagement of the EP4 receptor (2007) (3)
Levels of Prostaglandin EMetabolite , theMajor UrinaryMetabolite of Prostaglandin E 2 , Are Increased in Smokers (2005) (3)
Implications for Molecular-Based Chemoprevention Breast Cells through Transcription Factor Crosstalk : Down-regulates Cyclooxygenase-2 Expression in Human The Retinoid X Receptor-Selective Retinoid , LGD 1069 (2005) (2)
Gefitinib (’Iressa’, ZD1839) inhibits the expression of COX-2 and the growth of experimental head and neck squamous-cell carcinoma (2004) (2)
A multicenter phase II study of docosahexaenoic acid (DHA) in patients (pts) with a history of breast cancer (BC), premalignant lesions, or benign breast disease. (2014) (2)
DIETARY SATURATED FATTY ACIDS: A NOVEL TREATMENT FOR ALCOHOLIC LIVER DISEASE* (1998) (2)
Cancer and cardiovascular-related perceived risk in a diverse cancer center catchment area (2022) (2)
Crosstalk Between COX-2 and EGFR: A Potential Therapeutic Opportunity (2008) (2)
Obesity and Breast Cancer: Narrowing the Focus. (2015) (2)
Withdrawal: Peroxisome proliferator-activated receptor γ ligands suppress the transcriptional activation of cyclooxygenase-2: Evidence for involvement of activator protein-1 and CREB-binding protein/p300. (2020) (2)
Synthesis and use of a lysolecithin analog for the purification of UDP-glucuronosyltransferase. (1990) (2)
Advances in Brief A Novel Synthetic Oleanane Triterpenoid , 2-Cyano-3 , 12-dioxoolean-1 , 9-dien-28-oic Acid , with Potent Differentiating , Antiproliferative , and Anti-Inflammatory Activity 1 (1999) (2)
High-Fat Diet–Induced Obesity Alters Dendritic Cell Homeostasis by Enhancing Mitochondrial Fatty Acid Oxidation (2022) (2)
Blood Biomarkers Reflect the Effects of Obesity and Inflammation on the Human Breast Transcriptome. (2021) (2)
Breast Cancer Incidence After Risk-Reducing Salpingo-Oophorectomy in BRCA 1 and BRCA 2 Mutation Carriers (2012) (2)
( 1 )-Catechin Inhibits Intestinal Tumor Formation and Suppresses Focal Adhesion Kinase Activation in the Min/ 1 Mouse 1 (2000) (2)
Withdrawal: EP2 and EP4 receptors regulate aromatase expression in human adipocytes and breast cancer cells: Evidence of a BRCA1 and p300 exchange. (2020) (2)
Colonoscopic-Guided Pinch Biopsies in Mice as a Useful Model for Evaluating the Roles of Host and Luminal Factors in Colonic Inflammation. (2018) (1)
Talking to Doctors About Clinical Trials (2008) (1)
Association of a healthy lifestyle index with risk of breast cancer among women with normal body mass index in the UK Biobank. (2021) (1)
THE DEVELOPMENT OF AN IN VIVO MODEL FOR THE ASSESSMENT OF CIGARETTE SMOKING-ASSOCIATED ERECTILE DYSFUNCTION (2008) (1)
Abstract P4-04-12: Both metabolic syndrome and statin use are more common in women with breast inflammation (2015) (1)
Celecoxib and aromatase activity in breast cancer: Results from a prospective randomized preoperative trial. (2010) (1)
26 Vlcd-Induced Rapid Weight Loss Is Accompanied by Enhanced Lipolysis, Altered Adipose Tissues With Concomitant Changes in the Fecal Microbiome and Plasma Metabolome (2016) (1)
Dietary fat composition influences cell injury in experimental alcoholic liver disease and has divergent effects on the expression of liver fatty acid binding protein , and enzymes of extramitochondrial fatty acid oxidation (1996) (1)
Abstract LB-302: Celecoxib alters the intestinal microbiota and metabolome in association with reducing polyp burden (2016) (1)
Withdrawal: Hsp90 and PKM2 drive the expression of aromatase in Li-Fraumeni syndrome breast adipose stromal cells. (2020) (1)
Non-steroidal anti-inflammatory drugs and the risk of oral cancer in current and former smokers - [REMOVED] (2005) (1)
Increased trunk fat is associated with altered gene expression in breast tissue of normal weight women (2022) (1)
Body Fat Distribution, Cardiometabolic Traits, and Risk of Major Lower-Extremity Arterial Disease in Postmenopausal Women. (2021) (1)
Withdrawal: Peroxisome proliferator-activated receptor γ ligands suppress the transcriptional activation of cyclooxygenase-2: Evidence for involvement of activator protein-1 and CREB-binding protein/p300. (2020) (1)
IL-6-mediated induction of MMP-9 is modulated by JAK-dependent IL-10 expression in macrophages 1 (2013) (1)
Involvement of prostaglandin E receptor subtype EP4 in head and neck squamous cell carcinoma (HNSCC) (2005) (1)
Translating energy balance research from the bench to the clinic to the community: Parallel animal-human studies in cancer. (2023) (1)
Phenolic Antioxidants Induce UDP‐glucuronosyltransferase in Rat Liver a (1995) (1)
Epithelial Cells and in a Rat Model of Inflammation Activity and Expression of Cyclooxygenase-2 in Human Oral Inhibitory Effects of Caffeic Acid Phenethyl Ester on the Updated Version (1999) (1)
Perinephric white adipose tissue inflammation in clear cell renal cell carcinoma (ccRCC). (2017) (1)
Retraction: Increased Levels of COX-2 and Prostaglandin E2 Contribute to Elevated Aromatase Expression in Inflamed Breast Tissue of Obese Women. (2021) (1)
Abstract 3745: Exogenous and endogenous sources of serine contribute to colon cancer metabolism and growth (2020) (0)
Abstract CN07-02: Obesity, inflammation, and breast cancer (2015) (0)
Retraction: Carnosol, a Constituent of Zyflamend, Inhibits Aryl Hydrocarbon Receptor-Mediated Activation of CYP1A1 and CYP1B1 Transcription and Mutagenesis. (2022) (0)
Reduced expression of 15-PGDH contributes to elevated PGE2 levels in inflamed mucosa of IBD patients (2007) (0)
201 THE DEVELOPMENT OF AN IN VIVO MODEL FOR THE ASSESSMENT OF CIGARETTE SMOKING-ASSOCIATED ERECTILE DYSFUNCTION (2009) (0)
Abstract CN12-02: The prostaglandin-aromatase connection: Implications for breast carcinogenesis (2010) (0)
Abstract 3461: Psyllium protects against high fructose diet induced exacerbation of colitis and colitis associated colorectal carcinogenesis (2020) (0)
Abstract IA018: Linking obesity-associated inflammation with cancer metastasis (2021) (0)
Pilot study evaluating presence of crown-like structures in high grade endometrial carcinoma. (2015) (0)
913 Development of a Mouse Model of Inflammation-Dependent Pancreatic Cancer (2009) (0)
Abstract 1634: Metabolomic profiling for early detection of colorectal neoplasia (2012) (0)
Accounting for Height in an Analysis of Body Fat and Breast Cancer Risk-In Reply. (2019) (0)
P0008 Validating the link between obesity and breast inflammation in women with breast cancer (2014) (0)
Withdrawal: Hsp90 and PKM2 drive the expression of aromatase in Li-Fraumeni syndrome breast adipose stromal cells. (2020) (0)
Withdrawal: Histone deacetylase inhibitors suppress the induction of c-Jun and its target genes including COX-2. (2020) (0)
Withdrawal: Cyclooxygenase-2-derived prostaglandin E2 stimulates Id-1 transcription. (2020) (0)
AGA 2004 distinguished achievement award to Raymond N. Dubois, M.D., Ph.D. (2004) (0)
Systematic analysis of tobacco smoke induced changes in oral epithelial cell transcriptome. (2006) (0)
Withdrawal: Cyclooxygenase-2-derived prostaglandin E2 stimulates Id-1 transcription. (2020) (0)
Treating with her-2 / neu overexpression concomitant cancer (2000) (0)
White adipose tissue inflammation and breast cancer progression. (2015) (0)
Retraction: Dietary Polyphenols Suppress Elevated Levels of Proinflammatory Mediators and Aromatase in the Mammary Gland of Obese Mice. (2022) (0)
Retraction: Id1 Deficiency Protects Against Tumor Formation in ApcMin/+ Mice but not in a Mouse Model of Colitis-associated Colon Cancer. (2022) (0)
Abstract 3483: Measures of overall and central adiposity in relation to risk of obesity-related cancers among normal weight men and women in the UK Biobank (2020) (0)
Stimulates 2 Cyclooxygenase-2-derived Prostaglandin E Mechanisms of Signal Transduction : (2008) (0)
Abstract P1-06-03: Validating the link between obesity and breast inflammation in women with breast cancer (BC) (2013) (0)
Health Impact Assessment: A Step Toward Health in All Policies (vol 302, pg 315, 2009) (2009) (0)
Abstract 4048: Multiphoton tomographic imaging is an effective optical biopsy tool for detecting gastrointestinal inflammation and neoplasia (2012) (0)
Retraction: The Prostaglandin Transporter Regulates Adipogenesis and Aromatase Transcription. (2022) (0)
Dietary lipids coordinately regulate the expression of genes coding for xenobiotic hetabolizing enzymes (1993) (0)
Omeprazole Coinduces Multiple Xenobiotic‐metabolizing Enzymes in the Rat a (1995) (0)
Abstract 5245: Sulindac decreases basal-like mammary tumor burden and proinflammatory mediators in obese mice (2016) (0)
Performing Colonoscopic-Guided Pinch Biopsies in Mice and Evaluating Subsequent Tissue Changes. (2021) (0)
The Inflamed Fat-Cancer Connection (2019) (0)
Abstract MP29: Body Fat and Cardiovascular Disease Risk in Postmenopausal Women With Normal Body Mass Index: the Women’s Health Initiative (2019) (0)
Abstract PL02-04: The obesity-inflammation connection: Implications for breast carcinogenesis (2012) (0)
Celecoxib , a Select i ve Cyc lo-Oxygenase-2 Inhibi tor , Enhances the Response to Preoperat i ve Pacl i taxe l and Carboplat in in Early-Stage Non – Smal l-Cel l Lung Cancer (2003) (0)
Cyclooxygenase-2 hemmung (1998) (0)
Abstract 1251: Pioglitazone inhibits periprostatic white adipose tissue inflammation in obese mice (2017) (0)
Abstract 2876: Supplemental estrogen protects against obesity induced mammary gland inflammation in mice (2015) (0)
JAK-Dependent IL-10 Expression in Metalloproteinase-9 Is Modulated by Mediated Induction of Matrix - IL-6 (2017) (0)
Impact of obesity on survival in patients (pts) with early-stage squamous cell carcinoma (SCC) of the oral tongue. (2013) (0)
Retraction: Withdrawal: Microsomal prostaglandin E synthase-1 is overexpressed in inflammatory bowel disease: Evidence for involvement of the transcription factor Egr-1 (The Journal of biological chemistry (2004) 279 13 (12647-12658)) (2020) (0)
Abstract 4975: A small molecule pan Id protein antagonist shows strong antitumor activity (2017) (0)
A double-blind, placebo-controlled,randomized phase II study of celecoxib in patients with oral premalignant lesions (OPL). (2006) (0)
Effects of obesity on breast aromatase expression and systemic metabo-inflammation in women with BRCA1 or BRCA2 mutations (2021) (0)
chemokinesrole of oxidative stress, endotoxin, and Increased severity of alcoholic liver injury in female (2011) (0)
Abstract SY12-03: Obesity, inflammation and breast cancer (2015) (0)
Gender is a determinant of the severity of experimental colitis (2011) (0)
Induction of colitis-associated neoplasia in mice using azoxymethane and dextran sodium sulfate. (2021) (0)
Retraction: Pioglitazone, a PPARγ Agonist, Suppresses CYP19 Transcription: Evidence for Involvement of 15-Hydroxyprostaglandin Dehydrogenase and BRCA1. (2022) (0)
Cyclooxygenase-2 and α Evidence for the Role of TNF-MMP-3 Induce Macrophage MMP-9 : Matrix Metalloproteinase ( MMP )-1 and Barnhard (2009) (0)
Modulating Aha1 Expression Activity and Thereby Wnt Signaling by p53 Protein Regulates Hsp90 ATPase (2014) (0)
PD.163 Induction of COX-2 in the oral cavity ofsmokers. Evidence for crosstalk between COX-2 and EGFR (2005) (0)
Jun N-terminal Kinase: a potential target for the treatment of head and neck squamous cell carcinoma (HNSCC) (2005) (0)
Retraction: HSP90 Inhibitors Suppress Aryl Hydrocarbon Receptor-Mediated Activation of CYP1A1 and CYP1B1 Transcription and DNA Adduct Formation. (2022) (0)
MMP‐1 and MMP‐3 stimulate macrophage MMP‐9 expression by upregulating components of the PGE2 biosynthetic pathway (2008) (0)
Withdrawal: Histone deacetylase inhibitors suppress the induction of c-Jun and its target genes including COX-2. (2020) (0)
. inhibition de la cyclooxygenase-2 (1998) (0)
Prostaglandin E-2 inhibits transforming growth factor-beta-induced collagen A1(I) gene expression in human hepatic stellate cells; Implications for use of COX-2 inhibitors in patients with hepatic fibrosis (2002) (0)
Retraction: Obesity Is Associated With Inflammation and Elevated Aromatase Expression in the Mouse Mammary Gland. (2022) (0)
Evaluation of Cycloogenase-2 as a Novel Target for Breast Cancer Prevention (1999) (0)
Cancer Prevention: Novel Nutrient and Pharmaceutical Developments, New York, 13-14 November, 1998: Introduction (1999) (0)
Seminars in Oncology: Introduction (2004) (0)
Abstract 2815: Sulindac reverses an immunosuppressive tumor microenvironment associated with obesity-driven metastatic mammary tumors in mice (2019) (0)
P015 Metabolic syndrome and statin use are associated with pro-estrogenic breast inflammation (2015) (0)
Withdrawal: HDAC6 modulates Hsp90 chaperone activity and regulates activation of aryl hydrocarbon receptor signaling. (2020) (0)
Correction: Matrix Metalloproteinase-Dependent Microsomal Prostaglandin E Synthase-1 Expression in Macrophages: Role of TNF-α and the EP4 Prostanoid Receptor (2021) (0)
Cyclooxygenase-2 : A Potential Target for the Prevention and Treatment of Alcoholic Liver Disease (2004) (0)
Withdrawal: Microsomal prostaglandin E synthase-1 is overexpressed in inflammatory bowel disease: Evidence for involvement of the transcription factor Egr-1. (2020) (0)
Retraction: p53 Modulates Hsp90 ATPase Activity and Regulates Aryl Hydrocarbon Receptor Signaling. (2022) (0)
RESVERATROL, A NOVEL INHIBITOR OF CYCLOOXYGENASE-2 GENE EXPRESSION (2001) (0)
Matrix metalloproteinase (MMP)‐1 and MMP‐3 induced macrophage MMP‐9: Evidence for the role of microsomal prostaglandin synthase (mPGES)‐1 (2011) (0)
Traitement de cancers associes a une surexpression d'une famille de classe i de tyrosine kinases receptrices (2000) (0)
Increased trunk fat is associated with altered gene expression in breast tissue of normal weight women (2022) (0)
Withdrawal: p53 protein regulates Hsp90 ATPase activity and thereby Wnt signaling by modulating Aha1 expression. (2020) (0)
Perspectives in Cancer Prevention (1997) (0)
Retraction: Withdrawal: Hsp90 and PKM2 drive the expression of aromatase in Li-Fraumeni syndrome breast adipose stromal cells (The Journal of biological chemistry (2016) 291 31 (16011-16023)) (2020) (0)
Barrett's esophagus ablation combined with celecoxib, a Phase-II randomized controlled trial: initial safety results (2003) (0)
Obesity‐associated extracellular matrix remodeling promotes a tumor‐associated macrophage phenotype in tumor‐free breast adipose tissue (2018) (0)
Advances in Brief Cyclooxygenase-2 Expression Is Up-Regulated in Human Pancreatic Cancer 1 (1999) (0)
Evaluation of Cyclooxygenase-2 as a Novel Target for Breast Cancer Prevention (2001) (0)
the Breast Tissue of Obese Women with Breast Cancer Inflammation and Increased Aromatase Expression Occur in (2011) (0)
Abstract B36: Pyruvate kinase M2 regulates adipocyte differentiation and the expression of enzymes involved in glucose metabolism (2015) (0)
PerOXISOME PROLIFERATOR‐ACTIVATED RECEPTOR‐α‐MEDIATED GENE EXPRESSION AND ADAPTATION TO FATTY ACID OVERLOAD IN ALCOHOLIC LIVER DISEASE (1998) (0)
Abstract 1350: Macrophages induce COX-2 expression in breast cancer cells: Role of IL-1β dependent signal transduction pathways (2010) (0)
Characterization of cyclooxygenase-2 in human pathological disease (1999) (0)
Improving risk assessment of obesity-associated breast cancer. (2019) (0)
A translational study to investigate the association between smoking-induced lung inflammation and lung metastases (LM) from breast cancer (BC). (2012) (0)
Tu1669 NAFLD AND THE YMCA DIABETES PREVENTION PROGRAM: REPURPOSING AN EFFECTIVE LIFESTYLE INTERVENTION PROGRAM FOR THE TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE (2020) (0)
2874 Impact of white adipose tissue inflammation on survival in patients with squamous cell carcinoma of the oral tongue (2015) (0)
Introduction (1999) (0)
Alcoholic Liver Injury in the Rat Is Associated with Reduced Expression of Peroxisome Proliferator- (cid:1) (PPAR (cid:1) )-Regulated Genes and Is Ameliorated by PPAR (cid:1) Activation (2004) (0)
THE ASSOCIATION BETWEEN SARCOPENIA AND MOLECULAR SUBTYPES OF CLEAR CELL RENAL CELL CARCINOMA: MP72‐17 (2018) (0)
The development of an in-vivo model for the assessment of cigarette smoking-associated erectile dysfunction (2010) (0)
A review of recruitment methods for a translational research study. (2006) (0)
Abstract P5-07-05: Obesity, adipose inflammation, and race in patients with early stage breast cancer (2019) (0)
Leptin andAdiponectinModulate theSelf-renewal of Normal Human Breast Epithelial Stem Cells (2015) (0)
Incidence of periprostatic white adipose tissue inflammation in men with prostate cancer. (2017) (0)
Cyclooxygenase-2 targeted in vivo imaging of cancer (2007) (0)
Withdrawal: p53 protein regulates Hsp90 ATPase activity and thereby Wnt signaling by modulating Aha1 expression. (2020) (0)
Anti-tumor effects of an ID antagonist with no observed acquired resistance (2021) (0)
Abstract P2-08-05: Plasma lipidomics analysis to identify potential non-invasive biomarkers for breast white adipose inflammation and aromatase expression levels (2022) (0)
Withdrawal: Regulation of cyclooxygenase-2 mRNA stability by taxanes: Evidence for involvement of p38, MAPKAPK-2, and HuR. (2020) (0)
Abstract A46: Dietary weight loss and sulindac treatment each reverse obesity-associated inflammation and tumorigenesis in a mouse model of carcinogen-induced colon cancer (2020) (0)
Treatment and Prevention of Intraepithelial Neoplasia : An Important Target for Accelerated New Agent Development Recommendations of the American Association for Cancer Research Task Force on the Treatment and Prevention of Intraepithelial Neoplasia 1 (2002) (0)
Microsoft Word-macrophageSphkKOfinalRev2.docx (2013) (0)
Weight loss and/or sulindac mitigate obesity-associated transcriptome, microbiome, and protumor effects in a murine model of colon cancer. (2022) (0)
A BAYESIAN MODEL AVERAGING APPROACH FOR OBSERVATIONAL GENE EXPRESSION STUDIES By Xi (2011) (0)
Abstract P3-10-04: Obesity and adipose inflammation in men with breast cancer (2018) (0)
The prognostic significance of white adipose tissue inflammation in advanced-stage, high-grade, and serous endometrial cancers. (2019) (0)
Abstract 301: Microenvironmental regulation of epithelial-mesenchymal transitions in breast cancer metastasis. (2013) (0)
Chronic Inflammation Promotes Tobacco Carcinogen Associated Tumors In Lung Cancer Susceptible (A/J) And Resistant (B6) Mice (2010) (0)
Preliminary Pages / Contents / Preface (2003) (0)
Microbes Contribute to Chemopreventive Efficacy, Intestinal Tumorigenesis and the Metabolome. (2022) (0)
High Fat Diet Accelerates Esophageal Carcinogenesis in a Mouse Model of Barrett Esophagus (2017) (0)
Implications of obesity in breast cancer (2014) (0)
Abstract SY01-03: The obesity-inflammation connection: Implications for breast carcinogenesis. (2013) (0)
Retraction: Caloric Restriction Reverses Obesity-Induced Mammary Gland Inflammation in Mice. (2022) (0)
Abstract OT3-3-01: A multicenter phase II study of docosahexaenoic acid (DHA) in triple negative breast cancer (TNBC) survivors (2013) (0)
SAT-339 Cross-Talk with Breast Adipose Tissue Contributes to Obesity-induced DNA Damage in BRCA Mutant Breast Epithelial Cells (2019) (0)
Issue Information (2021) (0)
Doctor–Patient Interactions Regarding Clinical Trial Enrollment Questionnaire (2017) (0)
PPAR – alpha and alcoholic liver injury JPET # 64717 1 ALCOHOLIC LIVER INJURY IN THE RAT IS ASSOCIATED WITH REDUCED EXPRESSION OF PEROXISOME PROLIFERATOR-ALPHA ( PPAR α ) REGULATED GENES AND IS AMELIORATED BY PPAR α ACTIVATION (2004) (0)
Erratum: Dietary fatty acids are also drugs (Clinical Pharmacology and Therapeutics (1994) 55 (5-9)) (1994) (0)
Abstract 3966: The procancer effects of obesity can be reversed by moderate weight loss or an anti-inflammatory drug in a mouse model of colon cancer (2020) (0)
Abstract 2694: Target obesity-associated inflammation to decrease murine basal-like mammary tumor burden (2017) (0)
Retraction: Withdrawal: Histone deacetylase inhibitors suppress the induction of c-Jun and its target genes including COX-2 (The Journal of biological chemistry (2005) 280 38 (32569-32577)) (2020) (0)

This paper list is powered by the following services:

Other Resources About Andrew Jess Dannenberg

en.wikipedia.org

What Schools Are Affiliated With Andrew Jess Dannenberg?

Andrew Jess Dannenberg is affiliated with the following schools:

Andrew Jess Dannenberg's Academic­Influence.com Rankings